Carlo Maria Ferlini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Carlo Maria Ferlini has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Raffaele
Pediatric Surgery Unit, Department of Maternal and Child Health, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
2 shared publications - Giovanna Riccipetitoni
Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy
2 shared publications - Giulia Fusi
Pediatric Surgery Unit, Department of Maternal and Child Health, Policlinico San Matteo Fondazione, Pavia, Italy, Italy
2 shared publications - Mirko Bertozzi
Department of Pediatric Surgery, IRCCS San Matteo Polyclinic, University of Pavia, Pavia, 27100, Italy; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, 27100, Italy
2 shared publications - Emanuele Cereda
Clinical Nutrition and Dietetics Unit, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
1 shared publication - Luigi Avolio
Pediatric Surgery Unit, Department of Maternal and Child's Health, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi, 19, 27100, Pavia, Italy
1 shared publication
Latest Publications
- 7 October 2025
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 60 (12) , 162713
Pediatric Robotic Gynecologic Surgery: A Retrospective Institutional Experience and Systematic Review
- 7 October 2025
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 60 (12) , 162713
Pediatric Robotic Gynecologic Surgery: A Retrospective Institutional Experience and Systematic Review
- Open Access
- 27 August 2024
- Published by Springer Nature in Pediatric Surgery International
- Vol. 40 (1) , 1-5
Navigating the transition: a multidisciplinary approach to inflammatory bowel disease in children
Purpose: A multidisciplinary approach to Inflammatory Bowel Disease (IBD) has recently demonstrated a positive impact in pediatric patients, reducing dropout rates and facilitating the transition to adult care. Our study aims to evaluate how this approach influences disease activity, dropout rates, and transition. Methods: We conducted a longitudinal observational study including all patients diagnosed with IBD during pediatric-adolescent age, with a minimum follow-up period of 12 months. For each patient, endpoints included therapeutic approach, need for surgery and transition features. Results: We included 19 patients: 13 with Ulcerative Colitis (UC) and 6 with Crohn’s disease (CD). Most patients required multiple lines of therapy, with over 50% in both groups receiving biological drugs. Compliance was good, with a single dropout in each group (10, 5%). The need for surgery was significantly higher in the CD group compared to the UC group (16% vs. 7.7%, p < 0.01). Mean age at transition was significantly higher in the UC group compared to the CD group (19.2 ± 0.7 years SD vs. 18.3 ± 0.6 years SD, p < 0.05). Conclusions: In our experience, the multidisciplinary approach to IBD in transition-age patients appears effective in achieving clinical remission, offering the potential to reduce therapeutic dropouts.
- 27 August 2024
- Published by Springer Nature in Pediatric Surgery International
- Vol. 40 (1) , 1-5
Open AccessNavigating the transition: a multidisciplinary approach to inflammatory bowel disease in children
Purpose: A multidisciplinary approach to Inflammatory Bowel Disease (IBD) has recently demonstrated a positive impact in pediatric patients, reducing dropout rates and facilitating the transition to adult care. Our study aims to evaluate how this approach influences disease activity, dropout rates, and transition. Methods: We conducted a longitudinal observational study including all patients diagnosed with IBD during pediatric-adolescent age, with a minimum follow-up period of 12 months. For each patient, endpoints included therapeutic approach, need for surgery and transition features. Results: We included 19 patients: 13 with Ulcerative Colitis (UC) and 6 with Crohn’s disease (CD). Most patients required multiple lines of therapy, with over 50% in both groups receiving biological drugs. Compliance was good, with a single dropout in each group (10, 5%). The need for surgery was significantly higher in the CD group compared to the UC group (16% vs. 7.7%, p < 0.01). Mean age at transition was significantly higher in the UC group compared to the CD group (19.2 ± 0.7 years SD vs. 18.3 ± 0.6 years SD, p < 0.05). Conclusions: In our experience, the multidisciplinary approach to IBD in transition-age patients appears effective in achieving clinical remission, offering the potential to reduce therapeutic dropouts.